Biblio
“Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 436-41, 2011.
, “A comprehensive genetic association study of Alzheimer disease in African Americans.”, Arch Neurol, vol. 68, no. 12, pp. 1569-79, 2011.
, “Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.”, Nat Genet, vol. 43, no. 7, pp. 699-705, 2011.
, “Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.”, PLoS One, vol. 7, no. 12, p. e50640, 2012.
, “Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.”, PLoS Genet, vol. 8, no. 6, p. e1002707, 2012.
, “Genome-wide association analysis of age-at-onset in Alzheimer's disease.”, Mol Psychiatry, vol. 17, no. 12, pp. 1340-6, 2012.
, “A genome-wide scan for common variants affecting the rate of age-related cognitive decline.”, Neurobiol Aging, vol. 33, no. 5, pp. 1017.e1-15, 2012.
, “Overview and findings from the religious orders study.”, Curr Alzheimer Res, vol. 9, no. 6, pp. 628-45, 2012.
, “Overview and findings from the rush Memory and Aging Project.”, Curr Alzheimer Res, vol. 9, no. 6, pp. 646-63, 2012.
, “Alzheimer's disease: analyzing the missing heritability.”, PLoS One, vol. 8, no. 11, p. e79771, 2013.
, “Alzheimer's disease risk genes and the age-at-onset phenotype.”, Neurobiol Aging, vol. 34, no. 11, pp. 2696.e1-5, 2013.
, “Analyzing copy number variation using SNP array data: protocols for calling CNV and association tests.”, Curr Protoc Hum Genet, vol. 79, p. Unit 1.27., 2013.
, “CoRAL: predicting non-coding RNAs from small RNA-sequencing data.”, Nucleic Acids Res, vol. 41, no. 14, p. e137, 2013.
, “DRAW+SneakPeek: analysis workflow and quality metric management for DNA-seq experiments.”, Bioinformatics, vol. 29, no. 19, pp. 2498-500, 2013.
, “Exceptional memory performance in the Long Life Family Study.”, Neurobiol Aging, vol. 34, no. 11, pp. 2445-8, 2013.
, “GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.”, Neuron, vol. 78, no. 2, pp. 256-68, 2013.
, “HAMR: high-throughput annotation of modified ribonucleotides.”, RNA, vol. 19, no. 12, pp. 1684-92, 2013.
, “High-throughput identification of long-range regulatory elements and their target promoters in the human genome.”, Nucleic Acids Res, vol. 41, no. 9, pp. 4835-46, 2013.
, “Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).”, Transl Psychiatry, vol. 3, p. e256, 2013.
, “Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease.”, Cell, vol. 153, no. 3, pp. 707-20, 2013.
, “Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.”, Nat Genet, vol. 45, no. 12, pp. 1452-8, 2013.
, “Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.”, JAMA, vol. 309, no. 14, pp. 1483-92, 2013.
, “Alzheimer's disease genetics: from the bench to the clinic.”, Neuron, vol. 83, no. 1, pp. 11-26, 2014.
, “Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.”, Alzheimers Res Ther, vol. 6, no. 4, p. 39, 2014.
, “Cohort Profile: the Health and Retirement Study (HRS).”, Int J Epidemiol, vol. 43, no. 2, pp. 576-85, 2014.
,